Curebase is the leading provider of decentralized clinical research software and services, with the goal of powering research where any patient, anywhere can be part of clinical trials at home and with their own doctor. The Curebase platform enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform and virtual research site with features including digital recruitment, ePRO, eCOA, telemedicine, eConsent, eSource, and more.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/25/21 | $15,000,000 | Series A |
Bold Capital GGV Capital  Xfund | undisclosed |
| 05/05/22 | $40,000,000 | Series B |
aCrew Capital Bold Capital Gaingels GGV Capital Gilead Sciences Industry Ventures Positive Sum World Innovation Lab Xfund | undisclosed |
